Franklin Resources Inc Ascendis Pharma A/S Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Franklin Resources Inc holds 1,459,723 shares of ASND stock, worth $199 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,459,723

Previous 1,459,723 -0.0%

Holding current value

$199 Million

Previous $218 Million -0.0%

% of portfolio

0.07%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$113.0 - $153.43 $70.6 Million - $95.9 Million	-625,128 Reduced 29.98%	1,459,723 $218 Million
Q2 2024 Aug 14, 2024	BUY	$121.07 - $153.67 $12.5 Million - $15.8 Million	102,982 Added 5.2%	2,084,851 $284 Million
Q1 2024 May 13, 2024	BUY	$123.45 - $159.4 $113 Million - $146 Million	917,064 Added 86.13%	1,981,869 $300 Million
Q4 2023 Feb 09, 2024	SELL	$86.1 - $127.36 $12.8 Million - $18.9 Million	-148,480 Reduced 12.24%	1,064,805 $134 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $3,460 - $4,158	-40 Reduced -0.0%	1,213,285 $114 Million
Q2 2023 Aug 11, 2023	SELL	$69.96 - $97.84 $9.28 Million - $13 Million	-132,579 Reduced 9.85%	1,213,325 $108 Million
Q1 2023 May 12, 2023	SELL	$104.9 - $126.78 $3.32 Million - $4.01 Million	-31,618 Reduced 2.3%	1,345,904 $144 Million
Q4 2022 Feb 10, 2023	BUY	$99.42 - $131.97 $22.2 Million - $29.5 Million	223,430 Added 19.36%	1,377,522 $168 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $16.5 Million - $21.6 Million	196,055 Added 20.46%	1,154,092 $119 Million
Q2 2022 Aug 11, 2022	BUY	$78.08 - $117.61 $2.84 Million - $4.28 Million	36,356 Added 3.94%	958,037 $89.1 Million
Q1 2022 May 13, 2022	BUY	$102.18 - $135.75 $231,744 - $307,881	2,268 Added 0.25%	921,681 $108 Million
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $11.4 Million - $15.2 Million	89,702 Added 10.81%	919,413 $124 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $3.99 Million - $6.27 Million	35,448 Added 4.46%	829,711 $132 Million
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $7.53 Million - $8.99 Million	61,888 Added 8.45%	794,263 $104 Million
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $38,975 - $54,078	312 Added 0.04%	732,375 $94.4 Million
Q4 2020 Feb 10, 2021	BUY	$151.2 - $182.76 $2.51 Million - $3.04 Million	16,630 Added 2.32%	732,063 $122 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $2.34 Million - $2.68 Million	17,390 Added 2.49%	715,433 $110 Million
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $234,711 - $330,273	-2,117 Reduced 0.3%	698,043 $99.5 Million
Q1 2020 May 13, 2020	SELL	$97.01 - $145.11 $11.5 Million - $17.2 Million	-118,582 Reduced 14.48%	700,160 $78.8 Million
Q4 2019 Feb 12, 2020	SELL	$91.45 - $139.12 $5.44 Million - $8.28 Million	-59,492 Reduced 6.77%	818,742 $114 Million
Q3 2019 Nov 14, 2019	BUY	$95.8 - $118.9 $31,614 - $39,237	330 Added 0.04%	878,234 $84.6 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $30,312 - $37,381	-283 Reduced 0.03%	877,904 $101 Million
Q1 2019 May 14, 2019	BUY	$62.15 - $129.99 $16 Million - $33.5 Million	257,589 Added 41.51%	878,187 $103 Million
Q4 2018 Feb 12, 2019	BUY	$55.16 - $69.67 $1.58 Million - $2 Million	28,700 Added 4.85%	620,598 $38.9 Million
Q3 2018 Nov 13, 2018	BUY	$63.77 - $76.28 $2.73 Million - $3.26 Million	42,800 Added 7.79%	591,898 $41.9 Million
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $2.81 Million - $3.54 Million	47,931 Added 9.56%	549,098 $36.5 Million
Q1 2018 May 10, 2018	BUY	$38.98 - $68.04 $19.5 Million - $34.1 Million	501,167 New	501,167 $32.8 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Ascendis Pharma A/S Transaction History